How is the Mircera Market Poised for Growth: Trends and Opportunities Through 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the mircera market grown over the years?
In recent times, there has been a remarkable growth in the size of the mircera market. Projections show that it will rise from $2,679.57 million in 2024 to $2,835.52 million in 2025, yielding a compound annual growth rate (CAGR) of 5.8%. This significant growth during the historic period can be accredited to the rising instances of cancer, particularly in the elderly population, escalating demand for long-lasting erythropoiesis-stimulating agents (ESAs) for managing anemia, approval of Mircera in various regions, better access, increased knowledge about the treatment alternatives for anemia associated with CKD and cancer, as well as constant advancements in drug formulations to guarantee improved patient compliance.
What Is the forecasted market size and growth rate for the mircera market?
The market for Mircera is predicted to witness robust growth in the forthcoming years, reaching $3,506.29 million in 2029 with a 5.5% compound annual growth rate (CAGR). This expansion in the predicted period can be accredited to the anticipated increase in global cancer rates, more notably in underdeveloped areas, a sustained upswing in healthcare expenses, particularly in emerging markets, and a high need for inventive treatment alternatives for more effective anemia management. Additionally, the demand for anemia treatments and the uptake of Mircera in both outpatient and hospital situations are steadily rising. Key trends for the upcoming period include escalating demand for extended-release Erythropoiesis-Stimulating Agents (ESAs), advances in technology, development of healthcare infrastructure, increased utilization in the treatment of Chronic Kidney Disease (CKD), and a growing emphasis on drug delivery systems centered around the patient.
Get your mircera market report here!
https://www.thebusinessresearchcompany.com/report/mircera-global-market-report
What are the major factors driving growth in the mircera market?
The mircera market is anticipated to be boosted by the increasing occurrence of chronic kidney disease (CKD). CKD, a progressive loss of kidney function often linked to diabetes and hypertension, is a growing health issue. Various factors, including aging populations, changes in lifestyle, and enhanced medical diagnostics, contribute to the escalating rate of CKD. Anemia, a frequent CKD complication due to the decreased production of erythropoietin, necessitates the use of erythropoiesis-stimulating agents like mircera for effective hemoglobin level management. As per a June 2023 report by the UK-based non-profit Kidney Research UK, an estimated 7.2 million people in the UK, over 10% of the population, are currently living with CKD. Moreover, by 2033, the number of people affected by CKD is expected to increase to 7.61 million. Thus, the growing occurrence of CKD is fueling the mircera market’s expansion.
What key areas define the segmentation of the global mircera Market?
The mirceramarket covered in this report is segmented –
1) By Formulation: Injectable Solution; Pre-filled Syringes
2) By Indication: Anemia Due to Chronic Kidney Disease; Anemia in Cancer Patients
3) By Distribution Channel: Hospitals; Dialysis Centers; Specialty Clinics; Retail Pharmacies
4) By End User Patients: Adult Patients; Geriatric Patients
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19908&type=smp
What are the top market players propelling the growth of the mircera industry?
Major companies operating in the mircera market include Roche
What are the key trends shaping the future of the mircera market?
A dominant trend in the Mircera market is undeniably the emphasis on formulating approved therapies, especially benefitting children suffering from anemia related to chronic kidney disease. Pediatric patients, who are dealing with anemia resulting from chronic kidney disease (CKD), can greatly benefit from Mircera (methoxy polyethylene glycol-epoetin beta). This long-acting erythropoiesis-stimulating agent (ESA) boosts the production of red blood cells, curtails the need for regular injections, lessens the risk of blood transfusions, and elevates hemoglobin levels, thereby improving overall growth, wellbeing, and quality of life. For instance, in April 2024, the Switzerland-rooted pharmaceutical firm, Vifor Pharma, was granted extended approval by the FDA for Mircera (methoxy polyethylene glycol-epoetin beta) usage, encompassing children aged 3 months to 17 years afflicted with anemia connected to chronic kidney disease (CKD). This approval caters to both dialysis patients and those not undergoing dialysis, specifically for those switching from another erythropoiesis-stimulating agent (ESA) once their hemoglobin levels are regulated.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19908
What regions are dominating the mircera market growth?
North America was the largest region in the mircera market in 2024. The regions covered in the mircera market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Alpha Methyldopa Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/alpha-methyldopa-global-market-report
Polycystic Ovarian Syndrome Treatment Global Market Report 2025
Autoimmune Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
